688606.SH
Hangzhou Alltest Biotech Co., Ltd.
SSE · Healthcare · Medical - Instruments & Supplies · CN
CNY 44.61
+0.86%Year over year
Reported trailing growth
- Revenue
- +2.0%
- EBITDA
- —
- EBIT
- -42.4%
- EPS
- -44.1%
- Free cash flow
- -91.3%
- Operating cash flow
- -45.7%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -35.6%
- EBITDA
- -40.7%
- EBIT
- -43.5%
- Net income
- -42.9%
- EPS
- -42.9%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026